San Francisco, CANCT07090083Now EnrollingIRB Ready

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trial in San Francisco, CA

Access cutting-edge masld - metabolic dysfunction-associated steatotic liver disease treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Francisco

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access masld - metabolic dysfunction-associated steatotic liver disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related masld - metabolic dysfunction-associated steatotic liver disease treatment provided free

Apply for This San Francisco Location

Check if you qualify for this masld - metabolic dysfunction-associated steatotic liver disease clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Study in San Francisco

This proposal addresses a critical gap in our understanding of the impact of household food insecurity (FI) on pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) severity. There is evidence that children in families that do not have the ability to provide consistently healthy and high-quality foods, such as fruits and vegetables, have worse diet quality that children in households that are food secure. Additionally, evidence from adult studies link household FI to MASLD and liver fibrosis, and prior research of the PI has shown that exposure to household FI in early childhood was associated with a nearly 4 times increased odds of pediatric MASLD in middle childhood. Possible mechanisms linking household FI to pediatric MASLD include lower intake of fruits and vegetables, higher intake of caloric dense nutrient poor foods (e.g., sugar sweetened beverages), and less diversity of foods. Given consensus recommendations for the management of MASLD focus on lifestyle modification, i.e., diet and exercise to achieve weight loss, this proposal seeks to explore the association of household FI and pediatric MASLD disease severity and whether those effects are mediated by dietary intake. Study participants include children/adolescents with MASLD who are receiving care at UCSF's liver clinic and Weight Management for Teen and Child Health (WATCH) Clinic, a pediatric subspecialty clinic.

Sponsor: University of California, San Francisco

Who Can Participate

Inclusion Criteria

Children and adolescents receiving care in the liver and WATCH clinics.
Family living in California.
Parent/guardian speaks Spanish or English.
Child is between the ages of 6 to \<17 years.
Elevated ALT on at least 2 occasions within the past year:
ALT \> 22 units/L for females.
ALT \> 26 units/L for males.
BMI for age/sex ≥ 85%.
Alternatively, child has one elevated ALT within the past year and confirmed steatosis on imaging.
Family does not intend to move out of California within the next year.
Family is not already receiving EatSF SF Fruit and Vegetable Vouchers.
Family is not participating in any other dietary education programs besides those offered by the WATCH or liver clinics.

Exclusion Criteria

Child has an underlying condition or medication causing their weight gain (e.g., hypothyroidism, Prader-Willi syndrome, antipsychotic medications).
Child is on, or expected to go on, or starts on a weight loss medication (e.g., Qsymia or GLP-1 receptor agonists).
Child has another known cause of liver disease (not including MASLD or MASH), such as:
Autoimmune hepatitis.
Wilson's disease.
Hepatitis A, B, or C.
Acute infection.
Genetic condition causing inflammation in the liver.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT07090083) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Treatment Options in San Francisco, CA

If you're searching for masld - metabolic dysfunction-associated steatotic liver disease treatment options in San Francisco, CA, this clinical trial (NCT07090083) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced masld - metabolic dysfunction-associated steatotic liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all masld - metabolic dysfunction-associated steatotic liver disease clinical trials near you to find additional studies recruiting in your area.

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA